The trustees of Columbia University have filed a lawsuit claiming that Illumina is infringing on five of the school's gene-sequencing patents, reports Bloomberg News. The suit was filed in federal court in Wilmington, Del., and concerns patents awarded in 2009 on technologies developed by Columbia's Jingyue Ju and colleagues for rapid DNA sequencing, Reuters adds. Columbia has asked for damages and an injunction. "Columbia is proud of the outstanding research efforts of its faculty and will defend its patented technology," university spokesperson Robert Hornsby tells Reuters.
Illumina's Jennifer Temple tells Bloomberg that "we believe these claims are without merit, and we will defend against them vigorously."
Our sister publication GenomeWeb Daily News has more on this suit here.